Opinions
Alexander Lane, B Comm, C
Theratechnologies Inc
TH-T
BUY
Feb 06, 2007
Phase 3 shoed their drug did not have side effects. This resulted in a large move in the stock price. Now doing a financing, which will be a net positive for the stock. Could be a takeout or could be a partnership.
$8.470
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
BUY
Excellent phase 3 results. They are a takeover target, they have lots of cash. Annoyed at management because last month they had 61 million in cash, and decided to put the company up for sale, while at the same time decided to raise money. They can't have it both ways.
Nothing wrong with the product. Good one to hold and to buy. Should be stable.
biotechnology
pharmaceutical
PARTIAL BUY
Every biotech company always has some life-altering technology, and it's always way too positive. Small-mid caps like this can have big moves. Reversing a sideways trend, and breaking up to new levels, so that's positive. Maybe some movement up to $12. Take a small position, don't expose yourself too much. Support will be around $8.50, and if it breaks, start exiting.
biotechnology
pharmaceutical
Advertising